Published in Neuropharmacology on December 16, 2011
Intracranial self-stimulation to evaluate abuse potential of drugs. Pharmacol Rev (2014) 1.37
Combined cocaine hydrolase gene transfer and anti-cocaine vaccine synergistically block cocaine-induced locomotion. PLoS One (2012) 1.08
MeCP2 phosphorylation limits psychostimulant-induced behavioral and neuronal plasticity. J Neurosci (2014) 0.88
Substance abuse and movement disorders: complex interactions and comorbidities. Curr Drug Abuse Rev (2012) 0.83
Levetiracetam has opposite effects on alcohol- and cocaine-related behaviors in C57BL/6J mice. Neuropsychopharmacology (2013) 0.79
Methamphetamine increases locomotion and dopamine transporter activity in dopamine d5 receptor-deficient mice. PLoS One (2013) 0.77
Effects of the neuroactive steroid allopregnanolone on intracranial self-stimulation in C57BL/6J mice. Psychopharmacology (Berl) (2014) 0.76
Functional Maturation of Human Stem Cell-Derived Neurons in Long-Term Cultures. PLoS One (2017) 0.75
The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev (1993) 19.60
The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry (2005) 12.53
Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J Comp Physiol Psychol (1954) 6.65
Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods (1996) 6.41
Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron (2003) 6.19
Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature (2001) 5.65
Review. The incentive sensitization theory of addiction: some current issues. Philos Trans R Soc Lond B Biol Sci (2008) 5.54
Regulation of cocaine reward by CREB. Science (1998) 4.07
Cocaine experience controls bidirectional synaptic plasticity in the nucleus accumbens. J Neurosci (2007) 4.07
Behavioral sensitization to cocaine is associated with increased AMPA receptor surface expression in the nucleus accumbens. J Neurosci (2005) 3.99
Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J Neurosci (1996) 3.66
Long-term depression in the nucleus accumbens: a neural correlate of behavioral sensitization to cocaine. Nat Neurosci (2001) 3.41
Addictive drugs and brain stimulation reward. Annu Rev Neurosci (1996) 3.12
Review. Neurobiological mechanisms for opponent motivational processes in addiction. Philos Trans R Soc Lond B Biol Sci (2008) 2.97
CREB modulates excitability of nucleus accumbens neurons. Nat Neurosci (2006) 2.95
Extinction-induced upregulation in AMPA receptors reduces cocaine-seeking behaviour. Nature (2003) 2.86
Neurobiological evidence for hedonic allostasis associated with escalating cocaine use. Nat Neurosci (2002) 2.83
Conditioned withdrawal drives heroin consumption and decreases reward sensitivity. J Neurosci (2006) 2.74
Cocaine but not natural reward self-administration nor passive cocaine infusion produces persistent LTP in the VTA. Neuron (2008) 2.69
Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nat Protoc (2007) 2.63
Fluctuations in nucleus accumbens dopamine concentration during intravenous cocaine self-administration in rats. Psychopharmacology (Berl) (1995) 2.60
Drug-activation of brain reward pathways. Drug Alcohol Depend (1998) 2.53
Decreased brain reward produced by ethanol withdrawal. Proc Natl Acad Sci U S A (1995) 2.00
Repeated cocaine alters glutamate receptor subunit levels in the nucleus accumbens and ventral tegmental area of rats that develop behavioral sensitization. J Neurochem (1999) 1.86
Regulation of drug reward by cAMP response element-binding protein: evidence for two functionally distinct subregions of the ventral tegmental area. J Neurosci (2005) 1.84
Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents. J Neurosci (1996) 1.80
Initiation and adaptation: a paradigm for understanding psychotropic drug action. Am J Psychiatry (1996) 1.79
Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse? Trends Neurosci (2002) 1.77
Forebrain substrates of reward and motivation. J Comp Neurol (2005) 1.72
Molecular neuroadaptations in the accumbens and ventral tegmental area during the first 90 days of forced abstinence from cocaine self-administration in rats. J Neurochem (2003) 1.72
Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacology (Berl) (1989) 1.70
Different requirements for cAMP response element binding protein in positive and negative reinforcing properties of drugs of abuse. J Neurosci (2001) 1.67
Increased responsiveness of ventral tegmental area dopamine neurons to glutamate after repeated administration of cocaine or amphetamine is transient and selectively involves AMPA receptors. J Pharmacol Exp Ther (1997) 1.61
Dissociation of psychomotor sensitization from compulsive cocaine consumption. Neuropsychopharmacology (2006) 1.61
Repeated administration of amphetamine or cocaine does not alter AMPA receptor subunit expression in the rat midbrain. Neuropsychopharmacology (2002) 1.61
Extended access to cocaine self-administration enhances drug-primed reinstatement but not behavioral sensitization. J Pharmacol Exp Ther (2007) 1.58
Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system. J Pharmacol Exp Ther (1995) 1.54
Stress- and pharmacologically-induced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Res (1990) 1.51
Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward. Science (1975) 1.49
Predisposition to self-administer amphetamine: the contribution of response to novelty and prior exposure to the drug. Psychopharmacology (Berl) (1997) 1.46
Role of GluR1 expression in nucleus accumbens neurons in cocaine sensitization and cocaine-seeking behavior. Eur J Neurosci (2008) 1.44
Differential neurochemical and behavioral adaptation to cocaine after response contingent and noncontingent exposure in the rat. Psychopharmacology (Berl) (2006) 1.42
Brain reward systems and compulsive drug use. Trends Pharmacol Sci (2007) 1.42
The transition from controlled to compulsive drug use is associated with a loss of sensitization. Brain Res (2004) 1.40
The curve-shift paradigm in self-stimulation. Physiol Behav (1986) 1.38
Modulation of long-term depression by dopamine in the mesolimbic system. J Neurosci (2000) 1.35
Sensitization to the conditioned rewarding effects of cocaine: pharmacological and temporal characteristics. J Pharmacol Exp Ther (1995) 1.32
Altered sensitivity to rewarding and aversive drugs in mice with inducible disruption of cAMP response element-binding protein function within the nucleus accumbens. J Neurosci (2009) 1.30
Chronic intermittent amphetamine pretreatment enhances future appetitive behavior for drug- and natural-reward: interaction with environmental variables. Behav Brain Res (2002) 1.21
Repeated electrical stimulation of reward-related brain regions affects cocaine but not "natural" reinforcement. J Neurosci (2007) 1.21
Brain reward regulated by AMPA receptor subunits in nucleus accumbens shell. J Neurosci (2006) 1.17
Previous exposure to amphetamine increases incentive to obtain the drug: long-lasting effects revealed by the progressive ratio schedule. Behav Brain Res (2000) 1.14
Preexposure sensitizes rats to the rewarding effects of cocaine. Pharmacol Biochem Behav (1990) 1.12
Brain reward deficits accompany withdrawal (hangover) from acute ethanol in rats. Alcohol (2006) 1.11
Pre-exposure of rats to amphetamine sensitizes self-administration of this drug under a progressive ratio schedule. Psychopharmacology (Berl) (1998) 1.09
Behavioural sensitization and enhanced dopamine response in the nucleus accumbens after intravenous cocaine self-administration in mice. Eur J Neurosci (2003) 1.07
Increased breakpoints on a progressive ratio schedule reinforced by IV cocaine are associated with reduced locomotor activation and reduced dopamine efflux in nucleus accumbens shell in rats. Psychopharmacology (Berl) (2007) 1.06
Prolonged daily exposure to i.v. cocaine results in tolerance to its stimulant effects. Pharmacol Biochem Behav (2005) 1.06
Cocaine and SKF-82958 potentiate brain stimulation reward in Swiss-Webster mice. Psychopharmacology (Berl) (2002) 1.06
Inducible and brain region-specific CREB transgenic mice. Mol Pharmacol (2002) 1.04
Sensitization to cocaine's reinforcing effects produced by various cocaine pretreatment regimens in rats. Pharmacol Biochem Behav (2000) 1.02
Effects of selective D1 and D2 dopamine antagonists on cocaine self-administration in the rat. Psychopharmacology (Berl) (1991) 0.99
Differential distribution of CREB in the mesolimbic dopamine reward pathway. J Neurochem (2003) 0.96
Conditioned facilitation of brain reward function after repeated cocaine administration. Behav Neurosci (2003) 0.94
Brain-stimulation reward: a model for the study of the rewarding effects of abused drugs. NIDA Res Monogr (1992) 0.94
Morphine lowering of self-stimulation thresholds: lack of tolerance with long-term administration. Science (1977) 0.90
Deep brain stimulation in a rat model modulates TH, CaMKIIa and Homer1 gene expression. Eur J Neurosci (2007) 0.90
Behavioral sensitization is induced by intravenous self-administration of cocaine by rats. Psychopharmacology (Berl) (1996) 0.90
Self-stimulation in the rat: quantitative characteristics of the reward pathway. J Comp Physiol Psychol (1978) 0.89
Repeated exposure to rewarding brain stimulation downregulates GluR1 expression in the ventral tegmental area. Neuropsychopharmacology (2001) 0.88
Withdrawal from chronic cocaine administration induces deficits in brain reward function in C57BL/6J mice. Behav Brain Res (2011) 0.87
Synergistic effects of cocaine with lateral hypothalamic brain stimulation reward: lack of tolerance or sensitization. J Pharmacol Exp Ther (1997) 0.85
Cocaine self-administration in rats with histories of cocaine exposure and discrimination. Psychopharmacology (Berl) (2006) 0.84
The effect of chronic cocaine on self-stimulation train-duration thresholds. Pharmacol Biochem Behav (1988) 0.84
Induction of immediate early gene expression by high-frequency stimulation of the subthalamic nucleus in rats. Neuroscience (2006) 0.81
Locomotor activity and cocaine-seeking behavior during acquisition and reinstatement of operant self-administration behavior in rats. Behav Brain Res (2005) 0.80
Dopamine, a common substrate for the rewarding effects of brain stimulation reward, cocaine, and morphine. NIDA Res Monogr (1994) 0.79
Effects of repeated amphetamine injections on lateral hypothalamic brain stimulation reward and subsequent locomotion. Behav Brain Res (1993) 0.77
Enhanced self-stimulation responding from the substantia nigra after chronic amphetamine treatment: a role for conditioning factors. Pharmacol Biochem Behav (1980) 0.76
Lack of sensitization or tolerance to the facilitating effect of ventral tegmental area morphine on lateral hypothalamic brain stimulation reward. Brain Res (1993) 0.76
Newborn screening for Krabbe disease: the New York State model. Pediatr Neurol (2009) 2.88
Serologic markers of Lyme disease in children with autism. JAMA (2013) 1.67
Regional brain morphometry and impulsivity in adolescents following prenatal exposure to cocaine and tobacco. JAMA Pediatr (2013) 1.61
Childhood-onset schizophrenia: an open-label study of olanzapine in adolescents. J Am Acad Child Adolesc Psychiatry (1998) 1.59
Gene therapy for late infantile neuronal ceroid lipofuscinosis: neurosurgical considerations. J Neurosurg Pediatr (2010) 1.57
Definition and classification of hyperkinetic movements in childhood. Mov Disord (2010) 1.38
Exogenous contrast agent improves sensitivity of gradient-echo functional magnetic resonance imaging at 9.4 T. Magn Reson Med (2004) 1.21
L-type Ca2+ channels mediate adaptation of extracellular signal-regulated kinase 1/2 phosphorylation in the ventral tegmental area after chronic amphetamine treatment. J Neurosci (2004) 1.12
Cocaine exposure decreases GABA neuron migration from the ganglionic eminence to the cerebral cortex in embryonic mice. Cereb Cortex (2004) 1.12
NMDA receptors in the rat VTA: a critical site for social stress to intensify cocaine taking. Psychopharmacology (Berl) (2007) 1.11
Enhanced CREB and DARPP-32 phosphorylation in the nucleus accumbens and CREB, ERK, and GluR1 phosphorylation in the dorsal hippocampus is associated with cocaine-conditioned place preference behavior. J Neurochem (2008) 1.08
Cocaine and SKF-82958 potentiate brain stimulation reward in Swiss-Webster mice. Psychopharmacology (Berl) (2002) 1.06
Dysregulation of large-conductance Ca2+-activated K+ channel expression in nonsyndromal mental retardation due to a cereblon p.R419X mutation. Neurogenetics (2008) 1.06
Mephedrone (4-methylmethcathinone) and intracranial self-stimulation in C57BL/6J mice: comparison to cocaine. Behav Brain Res (2012) 1.03
Does drug abuse beget drug abuse? Behavioral analysis of addiction liability in animal models of prenatal drug exposure. Brain Res Dev Brain Res (2003) 1.03
Alcohol, cocaine, and brain stimulation-reward in C57Bl6/J and DBA2/J mice. Alcohol Clin Exp Res (2009) 1.01
Prenatal exposure to cocaine alters the development of conditioned place-preference to cocaine in adult mice. Pharmacol Biochem Behav (2007) 0.99
Dystonia in neurodegeneration with brain iron accumulation: outcome of bilateral pallidal stimulation. Brain (2010) 0.98
Pathway-specific dopaminergic deficits in a mouse model of Angelman syndrome. J Clin Invest (2012) 0.97
Prenatal exposure to cocaine increases the rewarding potency of cocaine and selective dopaminergic agonists in adult mice. Biol Psychiatry (2007) 0.97
BDNF-induced white matter neuroprotection and stage-dependent neuronal survival following a neonatal excitotoxic challenge. Cereb Cortex (2004) 0.96
Increased vulnerability to self-administer cocaine in mice prenatally exposed to cocaine. Psychopharmacology (Berl) (2002) 0.95
Neuropathological consequences of prenatal cocaine exposure in the mouse. Int J Dev Neurosci (2004) 0.94
Molecular switch from L-type Ca v 1.3 to Ca v 1.2 Ca2+ channel signaling underlies long-term psychostimulant-induced behavioral and molecular plasticity. J Neurosci (2010) 0.93
Potentiation of brain stimulation reward by morphine: effects of neurokinin-1 receptor antagonism. Psychopharmacology (Berl) (2011) 0.92
Regulation of tight junction permeability by calcium mediators and cell cytoskeleton in rabbit tracheal epithelium. Pharm Res (1993) 0.92
Psychostimulants, L-type calcium channels, kinases, and phosphatases. Neuroscientist (2005) 0.91
Markers of Celiac Disease and Gluten Sensitivity in Children with Autism. PLoS One (2013) 0.90
Altered cocaine-induced behavioral sensitization in adult mice exposed to cocaine in utero. Brain Res Dev Brain Res (2003) 0.90
Synthesis and secretion of mucous glycoprotein by the gill of Mytilus edulis. I. Histochemical and chromatographic analysis of [14C]glucosamine bioincorporation. Biochim Biophys Acta (1988) 0.89
Inhibition of endotoxin-induced lung inflammation by interleukin-10 gene transfer in mice. Am J Physiol Lung Cell Mol Physiol (2000) 0.88
Augmented constitutive CREB expression in the nucleus accumbens and striatum may contribute to the altered behavioral response to cocaine of adult mice exposed to cocaine in utero. Dev Neurosci (2005) 0.86
Chronic fluoxetine treatment selectively uncouples raphe 5-HT(1A) receptors as measured by [(35)S]-GTP gamma S autoradiography. Br J Pharmacol (2002) 0.86
Altered calcium homeostasis and cell injury in silica-exposed alveolar macrophages. J Cell Physiol (1993) 0.86
The transport barrier of epithelia: a comparative study on membrane permeability and charge selectivity in the rabbit. Pharm Res (1992) 0.85
Dopaminergic stimulation of fromtal ciliary activity in the gill of Mytilus edulis. Comp Biochem Physiol C (1975) 0.84
Enhanced dopamine D1 and BDNF signaling in the adult dorsal striatum but not nucleus accumbens of prenatal cocaine treated mice. Front Psychiatry (2011) 0.84
Lentiviral-mediated gene transfer of brain-derived neurotrophic factor is neuroprotective in a mouse model of neonatal excitotoxic challenge. J Neurosci Res (2006) 0.83
Preadolescent methylphenidate versus cocaine treatment differ in the expression of cocaine-induced locomotor sensitization during adolescence and adulthood. Biol Psychiatry (2006) 0.83
Brain-derived neurotrophic factor genotype impacts the prenatal cocaine-induced mouse phenotype. Dev Neurosci (2012) 0.82
Oligonucleotide targeting to alveolar macrophages by mannose receptor-mediated endocytosis. Biochim Biophys Acta (1996) 0.82
Case series: spectrum of neuroleptic-induced movement disorders and extrapyramidal side effects in childhood-onset schizophrenia. J Am Acad Child Adolesc Psychiatry (1998) 0.82
Augmentation of cocaine-sensitized dopamine release in the nucleus accumbens of adult mice following prenatal cocaine exposure. Dev Neurosci (2009) 0.81
Augmented D1 dopamine receptor signaling and immediate-early gene induction in adult striatum after prenatal cocaine. Biol Psychiatry (2008) 0.81
Preparation and in vitro evaluation of polylactic acid-mitomycin C microcapsules. J Microencapsul (1989) 0.80
Behavioral characterization of cereblon forebrain-specific conditional null mice: a model for human non-syndromic intellectual disability. Behav Brain Res (2011) 0.79
Levetiracetam has opposite effects on alcohol- and cocaine-related behaviors in C57BL/6J mice. Neuropsychopharmacology (2013) 0.79
Intracranial self-stimulation in FAST and SLOW mice: effects of alcohol and cocaine. Psychopharmacology (Berl) (2011) 0.79
Orexin-1 receptor antagonism does not reduce the rewarding potency of cocaine in Swiss-Webster mice. Brain Res (2011) 0.79
Prenatal L-DOPA exposure produces lasting changes in brain dopamine content, cocaine-induced dopamine release and cocaine conditioned place preference. Neuropharmacology (2010) 0.79
Kinetics of drug release from polylactic acid-hydrocortisone microcapsules. J Microencapsul (1989) 0.78
Hyperpolarizing effects of morphine, clonidine and 2-chloroadenosine in myenteric neurons associated with tolerance to morphine. J Pharmacol Exp Ther (1997) 0.78
Changes in sensitivity of reward and motor behavior to dopaminergic, glutamatergic, and cholinergic drugs in a mouse model of fragile X syndrome. PLoS One (2013) 0.78
Receptor-mediated peptide delivery in pulmonary epithelial monolayers. Pharm Res (1994) 0.77
Effects of prenatal cocaine exposure on social development in mice. Dev Neurosci (2014) 0.77
Characterization of proteolytic activities of pulmonary alveolar epithelium. Int J Pharm (2000) 0.77
A cell-based drug delivery system for lung targeting: II. Therapeutic activities on B16-F10 melanoma in mouse lungs. Drug Deliv (2001) 0.77
A method for the preparation of polylactic acid microcapsules of controlled particle size and drug loading. J Microencapsul (1989) 0.76
Ventilatory control in newborn mice prenatally exposed to cocaine. Pediatr Pulmonol (2002) 0.76
Prenatal-onset neurodevelopmental disorders secondary to toxins, nutritional deficiencies, and maternal illness. Handb Clin Neurol (2013) 0.76
Levetiracetam results in increased and decreased alcohol drinking with different access procedures in C57BL/6J mice. Behav Pharmacol (2014) 0.76
Structural brain imaging in children and adolescents following prenatal cocaine exposure: preliminary longitudinal findings. Dev Neurosci (2014) 0.76
Targeted gene delivery to alveolar macrophages via Fc receptor-mediated endocytosis. Pharm Res (1994) 0.76
Succinate metabolism in the gills of the mussels Modiolus demissus and Mytilus edulis. Comp Biochem Physiol B (1972) 0.76
Successful management of refractory neonatal seizures with midazolam. J Child Neurol (2008) 0.76
Alveolar permeability enhancement by oleic acid and related fatty acids: evidence for a calcium-dependent mechanism. Pharm Res (1994) 0.76
Still no time for complacency: Developmental effects of prenatal methamphetamine exposure. Neurology (2009) 0.75
Cup of Joe: a brain development "no"? Sci Transl Med (2013) 0.75
Psychostimulants, Protein phosphorylation and Gene expression: a growing role of L-type calcium channels. Cellscience (2005) 0.75
Binding of bisbenzylisoquinoline alkaloids to phosphatidylcholine vesicles and alveolar macrophages: relationship between binding affinity and antifibrogenic potential of these drugs. Exp Lung Res (1992) 0.75
Anaerobic cilio-excitation and metabolic stimulation by 5-hydroxytryptamine in bivalve gill. Comp Gen Pharmacol (1971) 0.75
Effects of the cilioexcitatory neurohumors dopamine and 5-hydroxytryptamine on cyclic AMP levels in the gill of the mussel Mytilus edulis. Life Sci (1979) 0.75
Neuro-developmental consequences of prenatal drug exposure. Preface. Dev Neurosci (2009) 0.75
Effects of bisbenzylisoquinoline alkaloids on alveolar macrophages: correlation between binding affinity, inhibitory potency, and antifibrotic potential. Toxicol Appl Pharmacol (1991) 0.75
Pharmacological characterization of the dopaminergic stimulation of mucociliary particle transport by Mytilus edulis gill. Gen Pharmacol (1981) 0.75
A cell-based drug delivery system for lung targeting: I. Preparation and pharmacokinetics. Drug Deliv (2001) 0.75
The disposition of tritiated dopamine by gills of Mytilus edulis and Modiolus demissus. Comp Biochem Physiol C (1977) 0.75
The metabolic fate of dopamine in the ciliated gill epithelium of bivalve molluscs. Comp Biochem Physiol C (1978) 0.75
Effect of testosterone on the concentration of ATP in the epithelium and muscle of the guinea-pig seminal vesicle. J Endocrinol (1973) 0.75
Effects of dopamine on anaerobic metabolism and ciliary activity in bivalve gills. Comp Gen Pharmacol (1974) 0.75
A source of error in the chromatographic study of 35S-sulfate labeled mucous glycoproteins secreted by the gill epithelium of Mytilus edulis. Prep Biochem (1986) 0.75